Your leading voice in digital health news
Twitter X Logo

Setting the agenda for next-gen precision cancer treatment 

29 April 2026
By Reesh Lyon
New research has found that while patients with the same cancer diagnosis can respond differently to treatment, clinicians still have limited tools at hand to predict who is most likely to benefit or suffer from a particular type of myeloma therapy. Myeloma – also known as multiple myeloma – is the second most common blood […]

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down